Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Adobe Systems Inc (ADBE) vs AstraZeneca plc (AZN) Price & Performance

Adobe Systems IncTrade
AstraZeneca plcTrade

Price performance (Past 24H)

Key statistics

Adobe Systems Inc vs AstraZeneca plc — how do they compare? Adobe Systems Inc trades at $260.66 (market cap $104.82B), while AstraZeneca plc trades at $157.96 (market cap $248.14B). The key difference: AstraZeneca plc is far larger — about 2.4× Adobe Systems Inc's market cap, and AstraZeneca plc pays a 2.01% dividend while Adobe Systems Inc pays none. Which is the better fit depends on your goals.

ADBEAZN
Market Cap
$104.82B$248.14B
Volume
5,187,646
Sector
TechnologyHealth
52-Week High
$367.46$209.48
52-Week Low
$193.41$147.06
Enterprise Value
$106.26B$275.41B
Dividend Yield
2.01%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Adobe Systems Inc

Adobe (ADBE) trades at $272.96, up 2.92% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with 2025 revenue of $23.77B and net income of $7.13B, maintaining exceptional profitability margins. Recent earnings beats and accelerating revenue growth contrast with market concerns about AI competition and CEO transition.

Adobe presents a compelling value opportunity trading below analyst consensus targets despite strong operational performance. Key risks include AI disruption threats and ongoing leadership transition, while institutional accumulation and positive earnings momentum support potential upside. The stock's current valuation multiples appear attractive relative to growth prospects.

AstraZeneca plc

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Adobe Systems Inc

Adobe Inc. develops, markets, and supports computer software products and technologies. The Company's products allow users to express and use information across all print and electronic media. Adobe offers a line of application software products, type products, and content for creating, distributing, and managing information.

Read more on ADBE

About AstraZeneca plc

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.

Read more on AZN